Á lódáil...
Progress in Immunotherapy for Non-small Cell Lung Cancer
In recent years, the five-year survival rate of patients with advanced stage non-small cell lung cancer (NSCLC) remains low despite recent advances in surgery, irradiation, chemotherapy, and targeted therapy. Immunotherapy which utilizes the immune system to control and eradicate cancer is a viable...
Na minha lista:
Main Authors: | , |
---|---|
Formáid: | Artigo |
Teanga: | Chinês |
Foilsithe: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2014-01-01
|
Sraith: | Chinese Journal of Lung Cancer |
Ábhair: | |
Rochtain Ar Líne: | http://dx.doi.org/10.3779/j.issn.1009-3419.2014.01.06 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|